Results 191 to 200 of about 2,996,306 (294)

Late-Onset Neutropenia After Rituximab in Multiple Sclerosis: Incidence, Predictors, and Outcomes in a Retrospective Multicenter Cohort. [PDF]

Neurol Neuroimmunol Neuroinflamm
Hallberg S, Kallin S, Evertsson B, Boremalm M, de Flon P, Salzer J, Lycke J, Fink K, Svenningsson A.   +8 more
europepmc   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Early- vs. late-onset gestational diabetes: Differential impact on maternal and neonatal outcomes. [PDF]

Acta Obstet Gynecol Scand
Li B, Ji W, Zhao R, Zhang J.
europepmc   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

Arthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein, Jennifer L. F. Lee, Evelyne Vinet, Arielle Mendel, Christian A. Pineau, Fares Kalache, Louis‐Pierre Grenier, Sasha Bernatsky   +7 more
wiley   +1 more source

Late-Onset Axial Spondyloarthritis in an Elderly Patient: A Case Report. [PDF]

Cureus
Kao P, Sam S, Eang M, Iv L, Ngy M.
europepmc   +1 more source

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

Arthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa, Yicheng Mu, Marie Hudson, Janet Pope   +3 more
wiley   +1 more source

Late-Onset Familial Primary Cardiac Angiosarcoma in Two Sisters. [PDF]

Interdiscip Cardiovasc Thorac Surg
Kawakami H, Tsuneyoshi H, Kyo S, Suzuki M.   +3 more
europepmc   +1 more source